US provides Additional $3m COVID-19 Assistance to Iraq

The United States, through the United States Agency for International Development (USAID), is pleased to announce an additional $3 million in urgent COVID-19 assistance for Iraq.

USAID's contribution will help Iraq better detect and diagnose COVID-19 infections, reduce COVID-19 cases and deaths, and broadly increase access to vaccines for Iraqis nationwide.

This assistance, implemented by UNICEF and the World Health Organization (WHO), will add up to 800 new COVID-19 vaccination locations, including in challenging humanitarian areas, such as in camps housing refugees and internally displaced persons.

It will also provide equipment and supplies, as well as technical assistance to Iraqi laboratories, clinics, and hospitals for testing, diagnosing, and treating COVID-19. USAID funding also will help train frontline workers on caring for COVID-19 patients and promote vaccination among the Iraqi public.

"As COVID-19 cases continue to surge in Iraq, this latest contribution from USAID will help our local partners better protect the people of Iraq through increased vaccination centers and enhanced prevention and treatment measures," said Robert Birkenes, USAID's Acting Mission Director to Iraq. "This is an example of our ongoing commitment to help save lives and defeat the pandemic together."

USAID has committed more than $60 million since the start of the pandemic to help Iraq respond to COVID-19. The $3 million in additional COVID-19 assistance funds from the American Rescue Plan Act builds on our August donation, in partnership with the Iraqi Ministry of Health, of more than 500,000 Pfizer vaccine doses through COVAX, the global initiative to equitably distribute safe and effective COVID-19 vaccines worldwide.

The activities implemented with this additional support will contribute to the overall goals of the Government of Iraq's National Strategic Preparedness and Response Plan and the National Vaccine Deployment Plan.

(Source: USAID)

Comments are closed.